Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2007
10/18/2007US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
10/18/2007US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis
10/18/2007US20070244097 Nicotinic AcetylcholineReceptor Ligands
10/18/2007US20070244086 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
10/18/2007US20070241670 Organic materials with phosphine sulfide moieties having tunable electric and electroluminescent properties
10/18/2007CA2648250A1 Deazapurines useful as inhibitors of janus kinases
10/18/2007CA2648170A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
10/18/2007CA2647690A1 Novel cyclobutyl compounds as kinase inhibitors
10/18/2007CA2647208A1 Glucokinase activators
10/17/2007EP1845098A1 Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
10/17/2007EP1844158A2 Biomarker for inflammatory bowel disease
10/17/2007EP1844057A1 Novel triazolopyrimidine derivatives
10/17/2007EP1844050A1 Pyrrolopyrimidines useful as inhibitors of protein kinase
10/17/2007EP1844049A1 Long wavelength shifted benzotriazole uv-absorbers and their use
10/17/2007EP1844048A1 Pyrazolopyrimidines as cell cycle kinase inhibitors
10/17/2007EP1844047A1 Hydrate of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]- pyramidin-7-yl}phenyl)acetamide and processes and methods related thereto
10/17/2007CN101056878A Azaindole carboxamides
10/17/2007CN101054380A Pyrazolopyrimidine derivative used as cell cycle dependency protein kinase inhibito
10/17/2007CN101054379A Pyrrole substituted pyrimidinone derivative, preparation method and use thereof in medicine
10/17/2007CN100343256C Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/17/2007CN100343255C Pyrazolo (1,5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
10/17/2007CN100343254C Pyrrolopyrimidine derivatives
10/17/2007CN100343253C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
10/17/2007CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/17/2007CN100343232C Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition
10/17/2007CN100342786C Microbicides asing triazolopyrimidine derivatives as protection materials
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282585 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy}quinoline
10/16/2007US7282582 Combining 1-monoacyldipyrromethane with a boron compound to produce a metal complex
10/16/2007US7282575 Functional peptide nucleic acid monomer and process for producing the same
10/16/2007US7282511 Isatine derivatives with neurotrophic activity
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2297124C Method for synthesis of halopyridyl-azacyclopentane derivative and intermediate thereof
10/16/2007CA2272584C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
10/11/2007WO2007114652A1 Novel benzimidazole monomers terminated with trifluorovinyloxy groups and polybenzimidazoles membrane prepared by using the same monomers
10/11/2007WO2007114398A1 Pyrazole-type cyanine dye
10/11/2007WO2007113647A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4υl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
10/11/2007WO2007113276A1 Novel bi-aryl amines
10/11/2007WO2007113136A1 Use of substituted triazolopyrimidines for controlling phytopathogenic harmful fungi
10/11/2007WO2007113000A1 3-SUBSTITUTED N-(ARYL- OR HETEROARYL)-PYRAZO[1,5-a]PYRIMIDINES AS KINASE INHIBITORS
10/11/2007WO2007112998A1 3-unsubstituted n-(aryl- or heteroarvl)-pyrazolori [1,5-a]pyrimidines as kinase inhibitors
10/11/2007WO2007092888A3 Hcv ns5b inhibitors
10/11/2007US20070238874 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
10/11/2007US20070238873 Process for the Preparation of Triazolopyrimidines
10/11/2007US20070238744 Use of 6-(2-Tolyl)-Triazolopyrimidines as Fungicides, Novel 6-(2-Tolyl)-Triazolopyrimidines, Method for the Production Thereof, Used There of for Controlling Harmful Fungi, and Agents Containing the Same
10/11/2007US20070238743 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007US20070238739 Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
10/11/2007US20070238728 Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
10/11/2007DE102006016426A1 Neuartige Cyclobutyl-Verbindungen als Kinase-Inhibitoren Cyclobutyl novel compounds as kinase inhibitors
10/11/2007CA2648369A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4?l)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
10/11/2007CA2647391A1 Kinase antagonists
10/11/2007CA2646515A1 3-unsubstituted n-(aryl- or heteroarvl)-pyrazolori [1,5-a]pyrimidines as kinase inhibitors
10/11/2007CA2646166A1 3-substituted n-(aryl- or heteroaryl)-pyrazo[1,5-a]pyrimidines as kinase inhibitors
10/11/2007CA2646088A1 Novel bi-aryl amines
10/10/2007EP1842851A2 Novel compounds
10/10/2007EP1841770A2 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/10/2007EP1841769A2 Purine derivatives compositions containing the same and use thereof against cancer
10/10/2007EP1841533A2 Base stable ionic liquids
10/10/2007EP1841430A2 Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
10/10/2007EP1638677A4 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1381608B1 Cyclohexylphenyl vasopressin agonists
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1300159B1 Remedies for cancer
10/10/2007EP0915880B1 Azolo triazines and pyrimidines
10/10/2007EP0815111B1 Analogues of n-acetylardeemin, method of preparation and uses thereof
10/10/2007CN101052640A Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
10/10/2007CN101052636A Compound containing fused ring and organic electroluminescent element employing the same
10/10/2007CN101052629A Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
10/10/2007CN101052620A Benzamide compound
10/10/2007CN101052533A Optical information recording medium and information recording method
10/10/2007CN101050218A Method for synthesizing MU ¿C oxygen substitutional binuclear metalloporphyrin
10/10/2007CN101050217A Method for synthesizing Vardenafil hydrochloric acid
10/10/2007CN101049576A Desulphurization catalyst of sulfosalt of phthalocyanine iron cobalt, and preparation method
10/10/2007CN100341947C Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides
10/10/2007CN100341876C Spiro-substituted pyrrolopyrimidines
10/10/2007CN100341875C Novel process for producting imidazo[1,2-b]pyridazine derivative
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279572 Process for the 2-stage synthesis of hexanitrohexaazaisowurtzitane starting from a primary amine
10/09/2007US7279570 Nanoscale discotic liquid crystalline porphyrins
10/09/2007US7279514 High-molecular-weight polymeric material comprising diketopyrrolopyrrole pigments
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279473 Administered singly or in combination with a second antineoplastic agent; cyclin-dependent kinase inhibitors, antiproliferative agents; coupling and cyclization of a 1-aminopyridazinium salt with a 2-alkylthio-4-alkynyl pyrimidine compound
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279469 Diaminotriazoles useful as inhibitors of protein kinases
10/09/2007US7279468 Integrin ligands
10/09/2007US7279444 for controlling undesirable plants
10/09/2007US7279314 Chemical substance having morphogenetic and growth-accelerating activities
10/09/2007US7279237 OLEDs doped with phosphorescent compounds
10/09/2007US7279235 That emit phosphorescent radiation from a triplet molecular excited state when voltage is applied, e.g., platinum octaethylporphine; display devices, vehicles, computers, televisions, printers, large area wall screens, theater screens, stadium screens, billboards, and signs.
10/09/2007CA2529400C Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
10/04/2007WO2007112402A1 Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
10/04/2007WO2007111514A1 Contrast agents for magnetic resonance imaging and spectroscopy consisting of a cyclic oligoamid core of 3 to 4 identical monomer units with 3 to 4 paramagnetic chelate side chains
10/04/2007WO2007111390A1 Stationary phase and column using cucurbituril bonded silica gel, and separation method of taxol using the column
10/04/2007WO2007111328A1 Improved process for producing carbapenem compound
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 573